Related Experiment Video

Updated: Jun 24, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells

Daniel V LaBarbera1, Katarzyna Modzelewska, Amanda I Glazar

  • 1Department of Medicinal Chemistry University of Utah, Salt Lake City, UT 84112, USA.

Anti-Cancer Drugs
|April 17, 2009
PubMed

Insights

Marine alkaloid naamidine A effectively triggers apoptosis, a programmed cell death, in tumor cells. This mechanism, independent of p53 and ERK1/2, shows promise for developing new cancer therapies.

Area of Science:

  • Marine natural products
  • Cancer biology
  • Cell death pathways

Background:

  • Apoptosis is crucial for development and removing damaged cells.
  • Cancer cells often evade apoptosis, contributing to tumor growth.
  • Marine natural products show potential as anticancer agents, with pro-apoptotic activity being a key property.

Purpose of the Study:

  • To further characterize the mechanism of action of the marine alkaloid naamidine A.
  • To investigate naamidine A's ability to induce apoptosis in tumor cells.
  • To determine if naamidine A's antitumorigenic activity in vivo is mediated by apoptosis.

Main Methods:

  • Cell death assays in cultured tumor cells, including annexin V staining and mitochondrial membrane potential assessment.
  • Analysis of caspase activation (caspases 3, 8, and 9).
  • Tumor xenograft assays in rodents to evaluate in vivo antitumorigenic activity and apoptosis induction.

Main Results:

  • Naamidine A induces apoptosis in cultured tumor cells, evidenced by annexin V staining, mitochondrial disruption, and caspase activation.
  • Naamidine A-induced cell death is dependent on caspases.
  • Naamidine A inhibits tumor xenograft growth and activates caspase 3 in vivo, indicating apoptosis contributes to its antitumor effect.
  • Apoptosis induction by naamidine A is independent of extracellular signal-regulated kinase 1/2 (ERK1/2) and functional p53.

Conclusions:

  • Naamidine A is a potent inducer of apoptosis in tumor cells through a caspase-dependent pathway.
  • Apoptosis plays a significant role in naamidine A's in vivo antitumorigenic activity.
  • Naamidine A's mechanism of action involves apoptosis induction independent of previously identified targets (ERK1/2) and p53.
  • Naamidine A warrants further investigation for its potential as a clinical cancer therapeutic.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...